{"id":"W2799715956","doi":"10.1177/247553031016a00101","title":"Ustekinumab and Marked Clinical Responses in Patients with Moderate to Severe Psoriasis","year":2010,"lang":"en","type":"article","venue":"Psoriasis Forum","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Ustekinumab; Medicine; Psoriasis; Placebo; Clearance; Psoriasis Area and Severity Index; Internal medicine; Clinical trial; Dermatology; Gastroenterology; Urology; Disease; Pathology; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005028129,0.0003665105,0.0005760588,0.0002717944,0.0002179172,0.00004247343,0.0002445223,0.0004795874,0.0002434442],"category_scores_gemma":[0.0003077311,0.0002890365,0.0001078347,0.0002829704,0.0001471061,0.0001808076,0.0001515979,0.0004107419,0.0002775624],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003451365,"about_ca_system_score_gemma":0.00008197725,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001066631,"about_ca_topic_score_gemma":0.001092547,"domain_scores_codex":[0.9976211,0.0003957282,0.00053159,0.0006912838,0.00008660046,0.0006736556],"domain_scores_gemma":[0.9987133,0.000384321,0.0001376736,0.0005409359,0.0001142818,0.0001094811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01429192,0.0004859891,0.8675566,0.0000104258,0.0002486023,0.000009177837,0.0002318018,0.000001892932,0.0005586966,0.0001830653,0.001746287,0.1146755],"study_design_scores_gemma":[0.01334982,0.0008411312,0.9710629,0.00004710761,0.0001456501,0.00001890601,0.0001572111,0.000003165889,0.001483297,0.0001754177,0.01225118,0.0004642009],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957975,0.000135837,0.00001830586,0.0004551508,0.00211062,0.0006506507,0.0001325979,0.00007972437,0.0006196582],"genre_scores_gemma":[0.9967014,0.00004060511,0.00074763,0.00032943,0.00007986899,0.0001049463,0.00007309434,0.00004421656,0.00187882],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1142113,"threshold_uncertainty_score":0.9999562,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01439317671202491,"score_gpt":0.2588268253634242,"score_spread":0.2444336486513992,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}